Page 49 - AN-4-4

Advanced Neurology Lipid metabolism and Parkinson’s disease

Cells. 2020;9(11):2495. 63. Taghizadeh M, Tamtaji OR, Dadgostar E, et al. The effects
of omega-3 fatty acids and vitamin E co-supplementation
doi: 10.3390/cells9112495
on clinical and metabolic status in patients with Parkinson’s
52. Area-Gomez E, De Groof AJC, Boldogh I, et al. Presenilins are disease: A randomized, double-blind, placebo-controlled
enriched in endoplasmic reticulum membranes associated trial. Neurochem Int. 2017;108:183-189.
with mitochondria. Am J Pathol. 2009;175(5):1810-1816.
doi: 10.1016/j.neuint.2017.03.014
doi: 10.2353/ajpath.2009.090219
64. Michelle HS, Beth L. N-3 (Omega-3) fatty acids: Effects on
53. Rizzuto R, De Stefani D, Raffaello A, Mammucari C. brain dopamine systems and potential role in the etiology
Mitochondria as sensors and regulators of calcium and treatment of neuropsychiatric disorders. CNS Neurol
signalling. Nat Rev Mol Cell Biol. 2012;13(9):566-578. Disord Drug Targets. 2018;17(3):216-232.
doi: 10.1038/nrm3412 doi: 10.2174/1871527317666180412153612
54. Barbuti PA, Guardia-Laguarta C, Yun T, et al. The role 65. Liu X, Yamada N, Maruyama W, Osawa T. Formation of
of alpha-synuclein in synucleinopathy: Impact on lipid dopamine adducts derived from brain polyunsaturated
regulation at mitochondria-ER membranes. NPJ Parkinsons fatty acids: Mechanism for Parkinson disease. J Biol Chem.
Dis. 2025;11(1):103. 2008;283(50):34887-34895.
doi: 10.1038/s41531-025-00960-x doi: 10.1074/jbc.M805682200
55. Hu M, Feng X, Liu Q, Liu S, Huang F, Xu H. The ion channels 66. Bousquet M, Calon F, Cicchetti F. Impact of ω-3 fatty acids
of endomembranes. Physiol Rev. 2024;104(3):1335-1385. in Parkinson’s disease. Ageing Res Rev. 2011;10(4):453-463.
doi: 10.1152/physrev.00025.2023 doi: 10.1016/j.arr.2011.03.001
56. Przygrodzka E, Plewes MR, Davis JS. Luteinizing hormone 67. She P, Gao B, Li D, et al. The transcriptional repressor HEY2
regulation of inter-organelle communication and fate of the regulates mitochondrial oxidative respiration to maintain
corpus luteum. Int J Mol Sci. 2021;22(18):9972. cardiac homeostasis. Nat Commun. 2025;16(1):232.
doi: 10.3390/ijms22189972 doi: 10.1038/s41467-024-55557-4
57. Gomaraschi M, Bonacina F, Norata GD. Lysosomal acid 68. Li P, Song C. Potential treatment of Parkinson’s disease
lipase: From cellular lipid handler to immunometabolic with omega-3 polyunsaturated fatty acids. Nutr Neurosci.
target. Trends Pharmacol Sci. 2019;40(2):104-115. 2022;25(1):180-191.
doi: 10.1016/j.tips.2018.12.006 doi: 10.1080/1028415X.2020.1735143
58. Dubland JA, Francis GA. Lysosomal acid lipase: At 69. Saiki S, Hatano T, Fujimaki M, et al. Decreased long-chain
the crossroads of normal and atherogenic cholesterol acylcarnitines from insufficient β-oxidation as potential
metabolism. Front Cell Dev Biol. 2015;3:3. early diagnostic markers for Parkinson’s disease. Sci
Rep. 2017;7(1):7328.
doi: 10.3389/fcell.2015.00003
doi: 10.1038/s41598-017-06767-y
59. Bogie JFJ, Haidar M, Kooij G, Hendriks JJA. Fatty acid
metabolism in the progression and resolution of CNS 70. Den Besten G, Van Eunen K, Groen AK, Venema K,
disorders. Adv Drug Deliv Rev. 2020;159:198-213. Reijngoud DJ, Bakker BM. The role of short-chain fatty
acids in the interplay between diet, gut microbiota, and host
doi: 10.1016/j.addr.2020.01.004 energy metabolism. J Lipid Res. 2013;54(9):2325-2340.
60. Xing B, Wang R, Kou T, Liu W, Zhu ZJ. Unraveling tissue- doi: 10.1194/jlr.R036012
specific fatty acid biosynthesis and inter-tissue crosstalk in
mice through stable-isotope tracing metabolomics. Adv Sci. 71. Magliocca G, Mone P, Di Iorio BR, Heidland A, Marzocco S.
2025;12:e03662. Short-chain fatty acids in chronic kidney disease: Focus on
inflammation and oxidative stress regulation. Int J Mol Sci.
doi: 10.1002/advs.202503662 2022;23(10):5354.
61. Sarchione A, Marchand A, Taymans JM, Chartier- doi: 10.3390/ijms23105354
Harlin MC. Alpha-synuclein and lipids: The elephant in the 72. Dalile B, Van Oudenhove L, Vervliet B, Verbeke K.
room? Cells. 2021;10(9):2452.
The role of short-chain fatty acids in microbiota-gut-
doi: 10.3390/cells10092452 brain communication. Nat Rev Gastroenterol Hepatol.
62. Ruipérez V, Darios F, Davletov B. Alpha-synuclein, lipids 2019;16(8):461-478.
and Parkinson’s disease. Prog Lipid Res. 2010;49(4):420-428. doi: 10.1038/s41575-019-0157-3
doi: 10.1016/j.plipres.2010.05.004 73. Bruning J, Chapp A, Kaurala GA, Wang R, Techtmann S,

Volume 4 Issue 4 (2025) 43 doi: 10.36922/AN025320086